Showing results (1-10 of 372) with videos related to
Sort By:
Pageof 38
Future Oncology (London, England)|November 15, 2017
Atezolizumab in urothelial bladder carcinomaZineb Hamilou, Pernelle Lavaud, Yohann LoriotHematology/Oncology Clinics of North America|May 7, 2021
Emerging Targeted Therapy for Bladder CancerConstance Thibault, Yohann LoriotExpert Review of Anticancer Therapy|March 1, 2018
Durvalumab in urothelial cancersPernelle Lavaud, Zineb Hamilou, Yohann Loriot, et al.Therapeutic Advances in Medical Oncology|January 25, 2021
Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancerPernelle Lavaud, Clément Dumont, Constance Thibault, et al.Bulletin Du Cancer|January 2, 2018
[Atezolizumab (Tecentriq®): Activity, indication and modality of use in advanced or metastatic urinary bladder carcinoma]Alice Bernard-Tessier, Clément Bonnet, Pernelle Lavaud, et al.Journal for Immunotherapy of Cancer|April 22, 2017
Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patientsLuc Cabel, Elika Loir, Gwenaelle Gravis, et al.Frontiers in Oncology|June 7, 2021
Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective StudyNicolas Epaillard, Pauline Parent, Yohann Loriot, et al.BMC Medicine|October 7, 2014
Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trialsPernelle Lavaud, Fabrice AndreEuropean Journal of Cancer (Oxford, England : 1990)|March 11, 2020
Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcomeEmeline Colomba, Grégoire Marret, Giulia Baciarello, et al.Clinical Genitourinary Cancer|May 1, 2020
Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 TrialClément Dumont, Giulia Baciarello, Pierre-Olivier Bosset, et al.Pageof 38